Search

दवा प्रतिरोधी संक्रमणों के लिए भारत ने नैफिथ्रोमाइसिन न�

In September this year, the Government of India banned the manufacture, sale and distribution of 328 Fixed-Dose Combination drugs (FDCs) after a protracted legal battle with manufacturers. The ban followed a report by a Supreme Court-mandated experts’ panel that not only was there no therapeutic justification for the ingredients in these drugs, but they can in fact pose health risks. This paper argues that the move against “irrational” and

Africa faces various challenges in ensuring equitable access to life-saving drugs. Drug prices in the continent are largely unregulated, making locally produced drugs more expensive than the imported ones. The African countries thus rely heavily on imports to meet their pharmaceutical needs. Further, the medicine delivery systems in the countries are encumbered by the poor implementation of regulatory policies, if they are in place at all. East A

The increasing range of cross-boundary health issues has prompted the integration of health into the discipline of diplomacy, and this trend is reflected in India-Africa partnership. India’s development partnerships are, however, predicated on the idea of development effectiveness, which requires active private sector engagement. By focusing on four opportunity sectors — medical tourism, tele-health, frugal innovations, and the pharmaceutica

मानसिक स्वास्थ्य संबंधी बीमारियों का उपचार बेहद जटिल काम होता है. इसका कारण यह है कि इन बीमारियों की प्रकृति प्रत्येक मामले में अलग-अलग होती है. इसके अलावा उपलब्ध औषधियों क